Tag: platform

Transaction finalized with issuance of 125,000 preferred MEME Coin shares; token transfer confirmed on BSCScan

VICTORIA, Seychelles, June 05, 2025 (GLOBE NEWSWIRE) -- MEXC, a leading global cryptocurrency exchange, is shaping its long-term strategy, based on its mission – making crypto more accessible to everyone and building trust within the community. Being a significant player in the market, MEXC drives the whole industry. The effect of its recent investments on the crypto space globally is hard to overestimate.

Recent independent analyses confirmed that the Company has successfully created a ligand conjugated nanoparticle that can target specific biomarkers on the surface of cancer cells

HYDERABAD, INDIA & REYKJAVIK, ICELAND (June 5, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide (“Alvotech”), and Dr. Reddy’s Laboratories Ltd., (BSE: 500124 | NSE: DRREDDY | NYSE: RDY | NSEIFSC: DRREDDY, along with its subsidiaries hereafter referred to as “Dr. Reddy’s”), today announced that the companies have entered into a collaboration and license agreement to co-develop, manufacture and commercialize a biosimilar candidate to Keytruda® (pembrolizumab) for global markets. Keytruda® (pembrolizumab) is indicated for the treatment of numerous cancer types. In 2024, worldwide sales of Keytruda were US$29.5 billion [1]. The collaboration combines Dr. Reddy’s and Alvotech’s proven capabilities in biosimilars, thereby, speeding up the development process and extending the global reach for this biosimilar candidate.